What is IntegraLabs?
IntegraLabs operates as a specialty laboratory focused on providing accurate and timely prescription drug analysis for healthcare providers. Their services are designed to assist clinicians in monitoring patient adherence to prescribed medication regimens and to test for illicit drugs, thereby mitigating risks associated with prescribing. The company utilizes advanced HPLC-MS/MS technology, known for its high sensitivity, selectivity, and wide dynamic range, offering superior analytical specificity compared to other methods. IntegraLabs serves a diverse clientele, including mental health facilities, family health clinics, pain management centers, addiction treatment facilities, reference laboratories, and hospitals. In 2013, the company expanded its scope to include genetic testing, leading to the formation of IntegraLabs MDG.
How much funding has IntegraLabs raised?
IntegraLabs has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in IntegraLabs
PPP
Public-Private Partnership
What's next for IntegraLabs?
With its recent strategic investment and substantial total funding, IntegraLabs is well-positioned for its next phase of growth. The company's focus on advanced diagnostic technology and its expansion into genetic testing suggest a strategic direction towards innovation and broadening its service offerings. This capital infusion is likely to fuel further technological development, market penetration, and potentially new service line introductions, reinforcing its competitive edge in the healthcare diagnostics sector.
See full IntegraLabs company page
